Insider Trading (Form 4)
See all →NASDAQ
IPX
Iperionx LTDBeverly Wyse, a Director of IPERIONX Ltd, reported multiple transactions in common stock on July 15, 2026.
NASDAQ
IPX
Iperionx LTDForm 4: IPERIONX Director Buys Shares
R Tony Tripeny, a Director of IPERIONX Ltd, purchased 3,846 shares of common stock on July 14, 2026 for $26.00 per share.
NASDAQ
IPX
Iperionx LTDForm 4: IPERIONX Director Buys Shares
Lorraine M Martin, a Director of IPERIONX Ltd, purchased 4,100 shares of common stock on July 10, 2026 for $24.51 per share.
NASDAQ
IPX
Iperionx LTDForm 4: IPERIONX President Buys Shares
Toby Edgcumbe Symonds, President of IPERIONX Ltd, purchased 2,040 shares of common stock on July 10, 2026 for $24.55 per share.
NASDAQ
IPX
Iperionx LTDForm 4: IPERIONX CEO Buys Shares
Anastasios Arima, Chief Executive Officer and a Director of IPERIONX Ltd, purchased 138,720 shares of common stock on July 10, 2026 for $3.58 per share.
NASDAQ
IPX
Iperionx LTDForm 4: IPERIONX Executive Buys Shares
Todd Hannigan, Executive Chairman and a Director of IPERIONX Ltd, purchased 525,000 shares of common stock on July 10, 2026.
Schedule 13G - Passive Investments
NASDAQ
IPX
Iperionx LTDRegal Funds Management Pty Limited has reported a 2.63% beneficial ownership stake in Iperionx Ltd, holding 8,811,766 shares.
NASDAQ
IPX
Iperionx LTDRegal Funds Management Pty Limited and Regal Partners Limited have disclosed a 5.92% beneficial ownership stake in Iperionx Limited, totaling 18,953,963 ordinary shares.
NASDAQ
IPX
Iperionx LTDRegal Funds Management Pty Limited and Regal Partners Limited have disclosed a significant 7.29% beneficial ownership stake in Iperionx Limited, comprising over 23 million shares.
NASDAQ
IPX
Iperionx LTDFMR LLC and Abigail P. Johnson have reported a continued beneficial ownership of 8.2% of IPERIONX LTD's common stock as of December 31, 2024, through an amended Schedule 13G filing.
NASDAQ
IPX
Iperionx LTDSCHEDULE 13G/A: FIL Limited and Affiliates Disclose 3.1% Stake in IperionX Ltd
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed a beneficial ownership of 3.1% in IperionX Ltd's common stock as of December 31, 2024.